Hepatitis B surface antigenemia (HBsAg) among pregnant women in Southern Nigeria

African Health Sciences

Volumn 13, Issue 4, 2013, Pages 1139-1143

  Utoo, Bernard T ^a  

^a BENUE STATE UNIVERSITY   (Nigeria)

Author keywords

Hepatitis B virus; Immunization; Routine screening; Sero prevalence

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; BLOOD; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MASS SCREENING; NIGERIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PREVALENCE; PROCEDURES; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TEACHING HOSPITAL; TRANSMISSION; URBAN POPULATION; VIROLOGY;

ADOLESCENT; ADULT; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HOSPITALS, TEACHING; HUMANS; MASS SCREENING; NIGERIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PREVALENCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; URBAN POPULATION;

EID: 84893911279     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: 10.4314/ahs.v13i4.39     Document Type: Article

References (26)

1. Tosun S Y, Yuceturk M, Benzergil S. The immunization of babies born of HBsAg positive pregnant women. Ege Tip Dergisi 2002; 41(1): 21-23.
2. Uyar Y, Cabar C, Balci A. Seroprevalence of hepatitis B virus among pregnant women in Northern Turkey. Hepatitis Monthly 2009; 9(2): 146-149.
3. Arfaoui D, Fkih M, Hafsa AE, Kaabia N, Azzouz M. Hepatitis B and pregnancy. Tunis Med 2010; 88(6): 383-389.
4. Chang MH. Hepatitis B virus infection. Semin Fetal Neonatal Med 2007; 12 (3):160-167.
5. Maddrey WC. Hepatitis B: an important public health issue. J Med Virol 2000; 61(3): 362-366.
6. Levy M, Koren G. Hepatitis B vaccine in pregnancy; maternal and fetal safety. Am J Perinatol 1991; 8(3): 227-232.
7. Ranger-Rogez S, Alain S, Denis F. Hepatitis viruses: mother to child transmission. Pathol Biol (Paris) 2002; 50(9): 568-575.
8. Tong S, Kim KH, Chante C, Wands J, Li J. Hepatitis B virus e Antigen variants. Int J Med Sci 2005; 2(1): 2-7.
9. Olokoba AB, Salawu FK, Danburam A, Olokoba LB, Midala JK, Badung LH et al. Hepatitis B virus infection amongst pregnant women in north Eastern Nigeria-A call for action. Nig J Clin Pract 2011; 14(1): 9-13.
10. Yang HI, Lu SN, You SL, Sun CA, Wang LY, Hsiao C K et al. Hepatitis B e Antigen and the risk for hepatocellular carcinoma. N Engl J Med 2002; 347(3): 168-174.
11. Onakewhor JUE, Okonofua FE. The prevalence of dual human immunodeficiency virus/Hepatitis C virus (HIV/HCV) infection in asymptomatic pregnant women in Benin City, Nigeria. Afr J Reprod health 2009; 13(2): 97-108.
12. Hepatitis B Foundation. Hepatitis B guidelines for pregnant women. Available at: info@www.hepb.org. November 2010.
13. Campbell KP, Lindley MC, Lentine D, Bhatt A. Hepatitis B virus evidence statement; screening, immunization and treatment. In: Campbell KP, Lanza A, Dixon R, Chattopadhyay S, Molinari N, Finch RA, eds. A purchaser's guide to clinical preventive services: moving science into coverage. Washington DC. National Business Group on Health, 2006.
14. Obi SN, Onah HE, Ezugwu FO. Risk factors for hepatitis B infection during pregnancy in a Nigerian Obstetric population. J Obstet Gynaecol 2006; 26(8): 770-772.
15. Akani CI, Ojule AC, Opurum HC, Ejilemele AA. Seroprevalence of hepatitis B surface antigen (HBsAg) in pregnant women in Port Harcourt, Nigeria. Niger Postgrad Med J 2005; 12(4): 266-270.
16. Rabiu KA, Akinola OI, Adewunmi AA, Omololu OM, Ojo TO. Risk factors for hepatitis B virus infection among pregnant women in Lagos, Nigeria. Acta Obstet Gynecol Scand 2010; 89(9): 1024-1028.
17. Biswas SC, Gupta I, Ganguly NK, Chawla Y, Dilawari, JB. Prevalence of hepatitis B surface antigen in pregnant mothers and its perinatal transmission: Trans R Soc Trop Med Hyg 1989; 83(5): 698-700.
18. Khalil MK, Al-Mazrou YY, Al-Jeffri M, Al-Ghamdi YS, Mishkhas A, Bakhish M, et al. Sero survey of hepatitis B surface antigen in pregnant Saudi women. East Mediterr Health J 2005; 11(4): 640-647.
19. Madzime S, Adem M, Mohomed K, Woelk GB, Mudzamiri S, Williams MA. Hepatitis B virus infection among pregnant women delivering at Maternity Hospital Harare Zimbabwe, 1996-1997. Cent Afr J Med 1999; 45(8): 195-198.
20. Sami S, Korejo R, Bhutta SZ. Prevalence ofhepatitis B and C: a Jinnah postgraduate Medical Center experience. J Obstet Gynaecol Res 2009; 35(3): 533-538.
21. Emechebe GO, Emordi IJ, Ikefuna AN, Ilechukwu GC, Igwe WC, Ejiofor OS et al. Hepatitis B virus Infection in Nigeria-a Review. Niger Med J 2009; 50(1): 18-22.
22. Li XM, Yang YB, Hou HY, Shi ZJ, Shen HM, Teng BQ, et al. Interruption of HBV intrauterine transmission: A clinical study. World J Gastroenterol 2003; 9(7): 1501-1503.
23. Xu WM, Cui YT, Wang L, Yang H, Lian ZQ, Li XM, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicenter randomized double blind placebo-controlled study. J Viral Hepatol 2009; 10(2): 94-103.
24. Su GG, Pan KH, Zhao NF, Fang SH, Yang DH, Zhou Y. Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol 2004: 10(6): 910-912.
25. Hiratsuka M, Minakami H, Koshizuka S, Sato I. Administration of interferon-alpha during pregnancy: effects on fetus. J Perinat Med 2000; 28(5): 372-376.
26. Bukbuk, DN, Bassi AP, and Mangoro ZM. Seroprevalence of hepatitis B surface antigen among primary school pupils in rural Hawal valley, Borno State, Nigeria. Journal of Community Medicine and Primary Health care 2005; 17(1): 20-23.